135 related articles for article (PubMed ID: 8856143)
1. A new class of bradykinin antagonists containing indanylglycine.
Gera L; Stewart JM
Immunopharmacology; 1996 Jun; 33(1-3):174-7. PubMed ID: 8856143
[No Abstract] [Full Text] [Related]
2. A new class of potent bradykinin antagonist dimers.
Gera L; Stewart JM; Whalley E; Burkard M; Zuzack JS
Immunopharmacology; 1996 Jun; 33(1-3):178-82. PubMed ID: 8856144
[No Abstract] [Full Text] [Related]
3. A new generation of bradykinin antagonists.
Stewart JM; Gera L; Hanson W; Zuzack JS; Burkard M; McCullough R; Whalley ET
Immunopharmacology; 1996 Jun; 33(1-3):51-60. PubMed ID: 8856115
[TBL] [Abstract][Full Text] [Related]
4. New bradykinin antagonists having very high potency at B1 receptors.
Gera L; Stewart JM; Whalley ET; Burkard M; Zuzack JS
Immunopharmacology; 1996 Jun; 33(1-3):183-5. PubMed ID: 8856145
[No Abstract] [Full Text] [Related]
5. Bradykinin receptor antagonists containing N-substituted amino acids: in vitro and in vivo B(2) and B(1) receptor antagonist activity.
Goodfellow VS; Marathe MV; Kuhlman KG; Fitzpatrick TD; Cuadrado D; Hanson W; Zuzack JS; Ross SE; Wieczorek M; Burkard M; Whalley ET
J Med Chem; 1996 Mar; 39(7):1472-84. PubMed ID: 8691478
[TBL] [Abstract][Full Text] [Related]
6. In vivo pharmacological profile of novel, potent, stable BK antagonists at B1 and B2 receptors.
Hanson WL; McCullough RG; Selig WM; Wieczorek M; Ross S; Whalley ET; Stewart JM; Gera L
Immunopharmacology; 1996 Jun; 33(1-3):191-3. PubMed ID: 8856147
[No Abstract] [Full Text] [Related]
7. New and highly potent bradykinin antagonists.
Knolle J; Breipohl G; Henke S; Wirth K; Schölkens B
Agents Actions Suppl; 1992; 38 ( Pt 1)():559-64. PubMed ID: 1334632
[No Abstract] [Full Text] [Related]
8. Hybrid peptides having mixed substance P (NK1), neurokinin A (NK2) and bradykinin (BK2) antagonist properties.
Srivastava VP; Goodfellow VS; Zuzack JS; Jones S; Francis M; Beckey VE; Whalley ET
Immunopharmacology; 1996 Jun; 33(1-3):194-7. PubMed ID: 8856148
[No Abstract] [Full Text] [Related]
9. Pseudopeptide analogs of bradykinin and bradykinin antagonists.
Vavrek RJ; Gera L; Stewart JM
Agents Actions Suppl; 1992; 38 ( Pt 1)():565-71. PubMed ID: 1466297
[TBL] [Abstract][Full Text] [Related]
10. Bradykinin antagonists do not require a D-aromatic amino acid residue at position 7.
Vavrek RJ; Gera L; Stewart JM
Agents Actions Suppl; 1992; 38 ( Pt 1)():572-81. PubMed ID: 1466298
[TBL] [Abstract][Full Text] [Related]
11. Comparative profile of novel potent bradykinin antagonists at human B1 and B2 receptors.
Burkard M; Zuzack JS; Jones S; Francis M; Whalley ET; Stewart JM; Gera L
Immunopharmacology; 1996 Jun; 33(1-3):186-90. PubMed ID: 8856146
[TBL] [Abstract][Full Text] [Related]
12. Non-selectivity of new bradykinin antagonists for B1 receptors.
Rhaleb NE; Gobeil F; Regoli D
Life Sci; 1992; 51(11):PL125-9. PubMed ID: 1326066
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of a novel, orally active, nonpeptide bradykinin B2 receptor antagonist, FR167344.
Inamura N; Asano M; Hatori C; Sawai H; Hirosumi J; Fujiwara T; Kayakiri H; Satoh S; Abe Y; Inoue T; Sawada Y; Oku T; Nakahara K
Eur J Pharmacol; 1997 Aug; 333(1):79-86. PubMed ID: 9311664
[TBL] [Abstract][Full Text] [Related]
14. Probing the bradykinin receptor: mapping the geometric topography using ethers of hydroxyproline in novel peptides.
Kyle DJ; Martin JA; Burch RM; Carter JP; Lu SF; Meeker S; Prosser JC; Sullivan JP; Togo J; Noronha-Blob L
J Med Chem; 1991 Aug; 34(8):2649-53. PubMed ID: 1652027
[No Abstract] [Full Text] [Related]
15. Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum.
Meini S; Patacchini R; Lecci A; Quartara L; Maggi CA
Eur J Pharmacol; 2000 Dec; 409(2):185-94. PubMed ID: 11104833
[TBL] [Abstract][Full Text] [Related]
16. Characterization of des-Arg9-bradykinin-induced contraction in guinea-pig gallbladder in vitro.
Cabrini DA; Calixto JB
Eur J Pharmacol; 1997 Jul; 331(1):31-8. PubMed ID: 9274927
[TBL] [Abstract][Full Text] [Related]
17. Bradykinin antagonists: synthesis and in vitro activity of bissuccinimidoalkane peptide dimers.
Cheronis JC; Whalley ET; Blodgett JK
Agents Actions Suppl; 1992; 38 ( Pt 1)():551-8. PubMed ID: 1466296
[TBL] [Abstract][Full Text] [Related]
18. Bradykinin antagonists with dehydrophenylalanine analogues at position 5.
Greiner G; Dornberger U; Paegelow I; Schölkens BA; Liebmann C; Reissmann S
J Pept Sci; 1998 Apr; 4(2):92-100. PubMed ID: 9620613
[TBL] [Abstract][Full Text] [Related]
19. Effect of stretching of the guinea-pig ileum upon its response to bradykinin and to bradykinin-potentiating peptides.
Shimuta SI; Sabia EB; Paiva AC; Paiva TB
Adv Biosci; 1978 Jul; 17():231-6. PubMed ID: 755698
[No Abstract] [Full Text] [Related]
20. A new type of bradykinin B2 receptor antagonists: bradykinin analogs with N-alkyl amino acids at position 2.
Reissmann S; Greiner G; Seyfarth L; Paegelow I; Werner H; Vietinghoff G; Boeckmann S; Schulz E; Wartner U; Gera L
Immunopharmacology; 1996 Jun; 33(1-3):73-80. PubMed ID: 8856118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
